November 1, 2000Pacing and Clinical Electrophysiology
Mid‐term Follow‐Up of Endocardial Biventricular Pacing
Why the study?
Does endocardial biventricular pacing improve functional status and hemodynamics in patients with drug-resistant end-stage heart failure?
Population
11 patients (3 women, 8 men, age 65 +/- 9 years) with drug-resistant end-stage congestive heart failure (CHF).
Design
Case_series
Follow-up
Mid-term
Authors
Discussion
Loading...
Member takes
Implication
May offer pacing option in refractory end-stage HF; hypothesis-generating and requires prospective confirmation.
Structured PICO
Does endocardial biventricular pacing improve functional status and hemodynamics in patients with drug-resistant end-stage heart failure?
P
Population
11 patients (3 women, 8 men, age 65 +/- 9 years) with drug-resistant end-stage congestive heart failure (CHF).
I
Intervention
Implantation of a strictly endocardial biventricular (BV) pacing system.
O
Outcome
Procedural success, safety, and functional improvement (NYHA class, QRS duration, hemodynamics).surrogate
Endocardial biventricular pacing is technically feasible and appears to improve functional class and hemodynamics in patients with drug-resistant end-stage heart failure.
Limitations
- Further studies are needed before it is used on a larger scale
Cite This Study
Jaı̈s et al. (2000) studied this question.